Our top RSV content of 2025 included how nirsevimab and clesrovimab changed RSV prevention among younger patients, as well as ...
RSV, or respiratory syncytial virus, is a common seasonal illness that affects the lungs and typically manifests in "mild, cold-like symptoms that resolve in one to two weeks," The Cut reports. The ...
Nirsevimab is recommended for preventing RSV lower respiratory tract infection in infants younger than one year in their ...
Respiratory syncytial virus (RSV) causes symptoms like sneezing and coughing. In children, especially those under 2 years old, RSV can also cause bronchiolitis, which is inflammation of the small ...
A surge of viral infections in the U.S. might be contributing to an ongoing amoxicillin shortage, even though antibiotics don't kill viruses. When you purchase through links on our site, we may earn ...
A doctor has issued an urgent 12-hour warning amid a spike in cases of a virus across the UK. According to the expert, healthcare workers are “seeing loads” of this illness at the moment.
Respiratory syncytial virus remains a leading cause of infant hospitalisation, making awareness and prevention essential for ...
Although this year’s ultra-high rates of RSV hospitalizations have recently fallen, the tripledemic of RSV, COVID-19, and influenza continues throughout the holiday season. Pediatric hospitals have ...
Respiratory Syncytial Virus is increasing in Northeast Florida, according to the Florida Department of Health.
PITTSBURGH — The Allegheny County Health Department announced Monday that it has received a supply of the 2024-2025 formula COVID-19 vaccines. The ACHD said people 6 months and older are highly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback